The impact of fasting on the interpretation of triglyceride levels for predicting myocardial infarction risk in HIV-positive individuals: the D:A:D study.


Autoria(s): Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
Data(s)

2011

Resumo

We assessed whether fasting modifies the prognostic value of these measurements for the risk of myocardial infarction (MI). Analyses used mixed effect models and Poisson regression. After confounders were controlled for, fasting triglyceride levels were, on average, 0.122 mmol/L lower than nonfasting levels. Each 2-fold increase in the latest triglyceride level was associated with a 38% increase in MI risk (relative rate, 1.38; 95% confidence interval, 1.26-1.51); fasting status did not modify this association. Our results suggest that it may not be necessary to restrict analyses to fasting measurements when considering MI risk.

Identificador

http://serval.unil.ch/?id=serval:BIB_B03DB4258B88

isbn:1537-6613 (Electronic)

pmid:21791653

doi:10.1093/infdis/jir329

isiid:000293304400007

Idioma(s)

en

Fonte

Journal of Infectious Diseases, vol. 204, no. 4, pp. 521-525

Palavras-Chave #Adult; Anti-HIV Agents/therapeutic use; Fasting/blood; Female; HIV Infections/blood; Humans; Male; Middle Aged; Myocardial Infarction/blood; Predictive Value of Tests; Retrospective Studies; Risk Factors; Triglycerides/blood
Tipo

info:eu-repo/semantics/article

article